Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM).
第一作者:
Geraldine,Kelly
第一单位:
Retroscreen Virology Limited (hVIVO), Queen Mary BioEnterprises Innovation Centre, 42, New Road, Whitechapel, London E1 2AX.
作者:
主题词
抗病毒药(Antiviral Agents);临床试验(主题)(Clinical Trials as Topic);人类(Humans);鼻腔(Nasal Cavity);聚合酶链反应(Polymerase Chain Reaction);呼吸道合胞体病毒感染(Respiratory Syncytial Virus Infections);呼吸道合胞病毒(Respiratory Syncytial Viruses);病毒载量(Viral Load)
DOI
10.1016/j.jviromet.2015.08.019
PMID
26335961
发布时间
2019-12-10
- 浏览25
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文